Evidence map›Paper›PMID 27184078›Full record

ArticleMolecular cell2016

Activation of Mitofusin2 by Smad2-RIN1 Complex during Mitochondrial Fusion.

Sanjay Kumar, Christopher C Pan, Nirav Shah, Sarah E Wheeler, Kari R Hoyt, Nadine Hempel, Karthikeyan Mythreye, Nam Y Lee

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Biomolecules · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Potential biomarkers and targets of mitochondrial dynamics.Clinical and translational medicine · 2021
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Sanjay KumarDivision of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
Christopher C PanDivision of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
Nirav ShahDivision of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
Sarah E WheelerDivision of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
Kari R HoytDivision of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
Nadine HempelDepartment of Pharmacology, Penn State University, Hershey, PA 17033, USA.
Karthikeyan MythreyeDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA.
Nam Y LeeDivision of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA; Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA; James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA. Electronic address: lee.5064@osu.edu.
The Ohio State University · USPennsylvania State University · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USUniversity of South Carolina · US

Funding

Targeting NMDA Receptors and Brain Estradiol to Rescue Memory in Aging FemalesP20GM109091 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI KIARIS, HIPPOKRATIS, RONINSON, IGOR B · 2014 to 2024
$25.2M
Mechanism of endoglin-targeted anticancer therapyR01CA178443 · NCI · UNIVERSITY OF ARIZONA · PI LEE, NAM Y · 2014 to 2018
$1.6M
NCI NIH HHS R01 CA178443NIGMS NIH HHS P20 GM109091
6 · The paper itself

Abstract

Smads are nuclear-shuttling transcriptional mediators of transforming growth factor-β (TGF-β) signaling. Although their essential nuclear roles in gene regulation during development and carcinogenesis are well established, whether they have important cytoplasmic functions remains unclear. Here we report that Smad2 is a critical determinant of mitochondrial dynamics. We identified mitofusin2 (MFN2) and Rab and Ras Interactor 1 (RIN1) as new Smad2 binding partners required for mitochondrial fusion. Unlike TGF-β-induced Smad2/3 transcriptional responses underlying mitochondrial fragmentation and apoptosis, inactive cytoplasmic Smad2 rapidly promotes mitochondrial fusion by recruiting RIN1 into a complex with MFN2. We demonstrate that Smad2 is a key scaffold, allowing RIN1 to act as a GTP exchange factor for MFN2-GTPase activation to promote mitochondrial ATP synthesis and suppress superoxide production. These results reveal functional implications between Smads and mitochondrial dysfunction in cancer and metabolic and neurodegenerative disorders.

Indexed as

Mitochondrial DynamicsA549 CellsAdenosine TriphosphateAnimalsChlorocebus aethiopsCOS CellsEnergy MetabolismGTP PhosphohydrolasesHeLa CellsHumansIntracellular Signaling Peptides and ProteinsMiceMitochondriaMitochondrial Membrane Transport ProteinsMitochondrial ProteinsPhosphorylationAdenosine TriphosphateGTP PhosphohydrolasesIntracellular Signaling Peptides and ProteinsMfn1 protein, humanMFN2 protein, humanMitochondrial Membrane Transport ProteinsMitochondrial ProteinsRIN1 protein, humanSmad2 ProteinSMAD2 protein, humanSuperoxides

Identifiers

PMID27184078
PMCPMC4877164
OpenAlexW2368910174

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.